SCHEMBL7054420

SCHEMBL7054420

COC(=O)c1cc(C(C)C)c(Oc2ccc(OC)c(C(C)C)c2)c(C(C)C)c1

nearest known ligand 0.57

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
RORC P51449 11/20 0.53
THRB P10828 7/20 0.53
THRA P10827 3/20 0.48
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282114 0.90 THRB (0.51) RORCTHRBTHRA
SCHEMBL7054452 0.88 THRB (0.57) RORCTHRBTHRA
SCHEMBL282476 0.88 RORC (0.66) RORCTHRBTHRA
SCHEMBL10239573 0.82 MAPT (0.58) KMT2AMEN1MAPT
SCHEMBL282165 0.77 THRB (0.53) RORCTHRBTHRA
SCHEMBL6368421 0.77 RORC (0.64) RORCTHRBTHRA
SCHEMBL5619231 0.76 THRB (0.73) RORCTHRBTHRA
SCHEMBL2788081 0.76 THRB (0.73) RORCTHRBTHRA
SCHEMBL7053361 0.74 NR3C1 (0.53) KMT2AMAPT
SCHEMBL282237 0.74 THRB (0.51) RORCTHRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102739-B1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2003-04-23 EP disclosed
US-6492424-B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2002-12-10 US disclosed
EP-1102739-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2001-05-30 EP disclosed
WO-2000007972-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2000-02-17 WO disclosed